|Bid||0.0000 x 900|
|Ask||0.0000 x 900|
|Day's Range||28.66 - 29.11|
|52 Week Range||21.98 - 34.69|
|PE Ratio (TTM)||N/A|
|Beta (3Y Monthly)||1.92|
|Expense Ratio (net)||0.75%|
ARK Investment Management LLC (ARK), a New York-based adviser focused solely on disruptive innovation, today launched the ARK Fintech Innovation ETF (ARKF)–an ETF that capitalizes on the burgeoning fintech ...
Health care investors should look to biotechnology sector-related ETFs that tap into some exciting new technologies that could translate into growth potential, such as CRISPR, biotech’s breakthrough of ...
The cost of sequencing a human genome has dropped significantly over the past years and genome editing is enabling new breakthroughs in medicine. On the upcoming webcast, The Power of Genome Editing: What ...
Ark Investment Management, the investment manager behind a series of unique Internet and technology exchange traded funds, could add to its ETF stable with a new fintech fund. “The product, the ARK Fintech ...
The future of genetic medicine — and DNA stocks — is extremely bullish over the long term. But as is normal of any emerging technology, there will be plenty of bumps along the road. The good news is that those bumps will provide many opportunities to buy DNA stocks along the way.
Unless you’ve been secretly living in a cave over the last few years, it’s easy to see how technology is changing our world. And it’s doing so at an exponential pace. Thanks to new advances in computing power, we are now able to do things that were considered science fiction only a few years ago. Leaps in machine learning, artificial intelligence and wireless connectivity are breathing life into new industries and disrupting old ones. The World Economic Forum has dubbed the movement the start of the Fourth Industrial Revolution.
Healthcare was the best-performing sector of the third quarter, jumping 14.1% - its highest quarterly gain since the first quarter of 2013.
In an attempt to hone in on the potential opportunities, one should consider the criteria used to identity a disruptive innovation and look to an exchange traded fund strategy that adapts to the changes. On the recent webcast (available On Demand for CE Credit), How Investors Can Identify Disruptive Innovation and What it Can Add to a Portfolio, Catherine Wood, Chief Investment Officer and CEO of ARK Invest, explained three broad criteria to isolate a disruptive innovation platform. Disruptive innovations should enable rapid cost declines and economic tipping points, cut across sectors and geographies, and spawn further innovation.
The month of August was solid for Wall Street driven by the dual tailwinds of solid corporate earnings and a booming economy. The Dow Jones and the S&P 500 notched their best performances for the month since 2014, climbing 2.1% and 3%, respectively, while the Nasdaq Composite logged its best August since 2000, with gains of 5.7%. Notably, the S&P 500 topped a new milestone of 2,900.
Braving all evils of emerging market and trade war fears, the S&P 500 index is on track to record the longest bull run in history. The benchmark is now up for 3,452 days and Aug 22 will mark 3,453 days since the S&P 500 hit its low of 666 on Mar 9, 2009. Since then, the index has risen more than 300% and is up more than 7% so far this year.Source: istockphoto.com/joxxxxjo etf
The healthcare sector and related ETFs have been among the best performing defensive plays this year as strong earnings and potential Trump administration actions on drug pricing drew greater investment ...
Biotechnology sector ETFs were among the best performers Tuesday, with Illumina (ILMN) shares surging after the genomics firm beat second-quarter expectations and raised its year-end outlook. Among the best performing ETFs of Tuesday, the Invesco Dynamic Biotech & Genome (PBE) increased 3.0%, ARK Genomic Revolution Multi-Sector ETF (ARKG) advanced 2.5% and iShares Nasdaq Biotechnology ETF (IBB) rose 2.0%. Evercore analyst Ross Muken said in that the Illumina stock story is "far too compelling to ignore," reports Allison Gatlin for Investor's Business Daily.
The healthcare sector is home to some disruptive technologies and cutting-edge companies. That sentiment is highlighted by the ARK Genomic Revolution Multi-Sector ETF (NYSEArca: ARKG). ARKG actively invests ...
This year's top-performing health care funds are beating the broader market by a wide margin, thanks partly to leading biotech stocks.
ARK Invest is making the best of its few exchange traded funds. Of six total ETFs, three are performing well enough to make IBD's ETF Leaders screen.
If Noah was a fund manager and animals could invest, he’d put them on these ARK ETFs for stellar returns–ARK Genomic Revolution Multi-Sector ETF (NYSEArca: ARKG), ARK Innovation ETF (NYSEArca: ARKK) and ...
The popular adage “Sell in May and Go Away” proved wrong this year as Wall Street is on track to log the best May in nine years. With just one trading session left to the month, the S&P 500 gained 3.3%, Dow Jones is up 3.1%, and Nasdaq Composite Index has moved up by 5.1% in May.Source: Shutterstock